Chemocentryx reported $23.72M in Debt for its second fiscal quarter of 2022.


Ok
Trading Economics members can view, download and compare data from nearly 200 countries, including more than 20 million economic indicators, exchange rates, government bond yields, stock indexes and commodity prices.

The Trading Economics Application Programming Interface (API) provides direct access to our data. It allows API clients to download millions of rows of historical data, to query our real-time economic calendar, subscribe to updates and receive quotes for currencies, commodities, stocks and bonds.

Please Paste this Code in your Website
width
height
Debt Change
Alnylam Pharmaceuticals ALNY:US $ 677.72M 1.01M
Amgen AMGN:US $ 36522M 332M
AstraZeneca AZN:LN 29528M 1571M
Bayer BAYN:GR € 44634M 2087M
Biogen BIIB:US $ 7277.2M 2M
Biomarin Pharmaceutical BMRN:US $ 1081.05M 0.99M
Bristol Myers Squibb BMY:US $ 42060M 2912M
Chemocentryx CCXI:US $ 23.72M 0.04M
GlaxoSmithKline GSK:LN 22111M 11217M
Glaxosmithkline GSK:US $ 22111M 11217M
Macrogenics MGNX:US $ 0M 0M
Mirati Therapeutics MRTX:US $ 0M 0M
Novartis NOVN:VX SF 31031M 244M
Sarepta Therapeutics SRPT:US $ 1100.87M 2.03M
Takeda 4502:JP Y 4602254M 256843M
Teva Pharmaceutical TEVA:IT 22.08B 835M
YTE INCY:US $ 34.19M 0.01M